Pharmaceutical Anti-Counterfeiting
Combating the Real Danger from Fake Drugs
Effective strategies to deal with the growing problem of counterfeit drugs Counterfeit and illegally diverted drugs are a global problem representing a serious threat to patients and to our healthcare systems. To combat fake medicines you need to understand both the problems and the solutions. This book gives you these vital perspectives. It not only provides a detailed examination of the causes and consequences of pharmaceutical counterfeiting, it also provides practical advice and tested and proven strategies to deal with this growing threat to the international drug supply. Moreover, it investigates and explains the tactics and technologie…
Mehr
CHF 73.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-1-118-02365-5
- EAN: 9781118023655
- Produktnummer: 13886361
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2011
- Seitenangabe: 426 S.
- Plattform: PDF
- Masse: 3'162 KB
Über den Autor
MARK DAVISON, CEO of Blue Sphere Health, is a pharmaceutical consultant and entrepreneur with more than twenty years of industry experience. He was formerly business development director for healthcare at SICPA, one of the world's leading anti-counterfeiting and product security technology providers, where he gained an in- depth, global perspective on counterfeit pharmaceuticals and medical devices. He is a writer, seminar leader, and international conference speaker on pharmaceutical security matters. His article Drugs for the Developing World: Obligation, Opportunity and Threat won the Royal Society of Medicine Oswald Morton Essay Prize in 2010.
18 weitere Werke von Mark Davison:
Bewertungen
Anmelden